AK135 in Patients With Chemotherapy-Induced Peripheral Neuropathy (CIPN)

Clinical trial NCT06860789 · NOT_YET_RECRUITING

Trial details

NCT number: NCT06860789
Sponsor: Akeso
Status: NOT_YET_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Chemotherapy-induced Peripheral Neuropathy (CIPN)

Start date: 2025-02-28
Primary completion: 2026-03-31
Enrollment: 85

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.